Skip to main content

Table 3 Changes in CVD risk factor assessment, CVD targets and prescribing behaviours post-intervention compared to baseline

From: Findings and lessons learnt implementing a cardiovascular disease quality improvement program in Australian primary care: a mixed method evaluation

 

OR (95% CI) post-intervention compared to baseline

Total post-intervention sample in 15 practices (n = 40,256)

Cardiovascular risk assessment level post-intervention

Low/moderate (n = 17,365)

High (n = 2334)

Established CVD (n = 4975)

Risk factor assessment

 Blood pressurea

1.23 (0.90-1.70)

1.36 (0.82-2.25)

1.12 (0.85-1.48)

1.22 (0.80-1.86)

 Blood lipidsb

1.22 (0.94-1.58)

1.21 (0.75-1.95)

1.40 (0.56-3.49)

1.29 (0.93-1.79)

 BMIb

1.19 (0.99-1.42)

1.19 (0.95-1.50)

1.40 (0.90-2.19)

1.17 (0.93-1.46)

 Waistb circumferenceb

1.32 (0.74-2.35)

1.27 (0.61-2.65)

1.41 (0.81-2.45)

1.34 (0.88-2.03)

 Smoking statusb

1.17 (0.91-1.48)

1.13 (0.91-1.38)

1.09 (0.75-1.38)

1.11 (0.88-1.38)

CVD risk factors

 Overweight/obesity

0.97 (0.94-1.00)

0.96 (0.91-1.01)

0.80 (0.63-1.02)

1.00 (−.90-1.11)

 Waist circumferencec

1.02 (0.68- 1.53)

0.99 (0.62-1.60)

0.86 (0.61-1.22)

1.07 (0.73-1.55)

 Current smoker

0.99 (0.94- 1.05)

0.91 (0.81-1.02)

1.05 (0.98-1.13)

1.05 (0.92-1.20)

CVD targets achieved

 Blood pressure

1.02 (0.90-1.16)

1.08 (0.97-1.21)

0.99 (0.70-1.40)

1.16 (1.02-1.33)

 Total cholesterol

0.99 (0.92-1.06)

0.99 (0.91-1.08)

1.15 (0.90-1.46)

0.95 (0.84-1.07)

 LDL cholesterol

0.98 (0.92-1.04)

1.00 (0.94-1.06)

1.00 (0.83-1.20)

0.98 (0.87-1.11)

 HDL cholesterol

1.08 (0.99-1.18)

1.09 (1.00-1.20)

0.99 (0.84-1.13)

1.08 (0.95-1.23)

Prescribed CVD risk-reducing medications

 Prescribed risk-reducing medication(s)d

1.07 (0.97-1.19)

0.96 (0.91-1.02)

  1. aAssessed in the past 12 months
  2. bAssessed in the past 2 years
  3. c‘At risk’ waist circumference > 94 cm for males and > 80 cm for females
  4. dGuideline-recommended treatment was defined as [1] For high-risk patients the prescription of a BP-lowering medication and a statin [5]; for patients with established CVD, prescription of a BP-lowering medication, a statin and either an antiplatelet or an anticoagulant agent (see Appendix 1 for specific medications)